Eli Lilly (NYSE: LLY) holds a market cap of approximately $948.61 billion as of February 2026, ranking it the 13th most valuable public company globally. The Indianapolis-based pharma giant, founded in 1876, crossed the $900 billion threshold after years of accelerating growth driven by its drug pipeline.
Market Cap Of Eli Lilly
Year-On-Year Eli Lilly Market Cap
| Year | Market Cap (USD) | Year-on-Year Change |
|---|---|---|
| 2026 | $948.61 B | -1.82% |
| 2025 | $966.15 B | +37.18% |
| 2024 | $704.31 B | +27.28% |
| 2023 | $553.36 B | +59.19% |
| 2022 | $347.61 B | +31.56% |
| 2021 | $264.22 B | +63.60% |
| 2020 | $161.50 B | +28.34% |
| 2019 | $125.84 B | +2.83% |
| 2018 | $122.38 B | +31.60% |
| 2017 | $92.99 B | +14.54% |
| 2016 | $81.19 B | -12.81% |